SUBSCRIBE
SUBSCRIBE
News   FDA

Genentech, Inc. (JOBS), OSI Pharmaceuticals, Inc. Warn Of Liver Damage From Tarceva, 2 Deaths

September 23, 2008 | 
1 min read
WASHINGTON (Reuters) - Genentech Inc and OSI Pharmaceuticals have alerted doctors about cases of liver damage among patients who took the cancer drug Tarceva, U.S. regulators said on Tuesday.
FDA Approvals Regulatory
MORE ON THIS TOPIC
Podcast
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
April 1, 2026
 · 
1 min read
 · 
Heather McKenzie
Magnifier magnifying exclamation mark on red background. Alert and precaution concept. Caution and risk management security signal announcement hazard and dangerous notice symbol
Regulatory
FDA Ties Amgen’s Rare Inflammatory Disease Drug to Eight Deaths, Dozens of Liver Injuries
April 1, 2026
 · 
2 min read
 · 
Tristan Manalac
Success to win in business competition, overcome obstacles or motivation to solve problem and lead company achievement concept, confident businessman leader jump high over 3 hurdles to be winner.
Approvals
Biogen Bounces Back With FDA Nod for High-Dose Spinal Muscular Atrophy Drug
March 30, 2026
 · 
3 min read
 · 
Tristan Manalac
FDA
Webinar: Aligning With the FDA on a Regulatory Pathway To Avoid Decision Day Surprises
March 27, 2026
 · 
1 min read
 · 
Heather McKenzie